Keensight Capital - European Growth Buyout investor

At Keensight Capital,
we grow together.

Industry experts.
Partners in growth.

Keensight Capital is a European Growth Buyout investor with deep expertise in Technology and Healthcare. We partner with the management teams of fast growing and profitable companies providing capital, strategic guidance and operational support.

About us

Latest activities

Filter

All Press Release

Press Release

Keensight Capital appoints Rafe Hafeez as M&A Director

May 24, 2023

Press Release

Neuraxpharm agrees on the divestment of inhalation API specialist Inke to Keensight Capital

April 27, 2023

Press Release

Keensight Capital appoints Cindy Giraud as Communications Director

March 20, 2023

Press Release

Main Capital and Keensight Capital agree on the sale of Onventis, a leading cloud procurement provider for medium-sized businesses

January 26, 2023

Latest deals

Onventis

Leading all-in-one cloud procurement platform for mid-sized enterprises in Europe

Quanos

Global leading software provider for industrial aftersales and digital technical documentation

AXXAM

Global drug discovery Contract Research Organization

BYG4lab

Leading provider of data management software solutions for medical laboratories

Companies

Our CEOs talk about Keensight Capital

Stories

Key figures

years of experience in Technology and Healthcare

10-400^m€
investment tickets

5^bn€

assets under management

IRR from a total of 48 exited investments

nationalities in the team

average annual portfolio revenue growth over the past 5 years